Health Care Consumer Protection Advisory Commission Focuses on Process, Authority, and Expectations in First February Meeting
At its rescheduled February 9 meeting, the Health Care Consumer Protection Advisory Commission (HCPAC) did not award funds or advance specific projects. Instead, the hour-long discussion focused almost entirely on how proposals could be submitted, evaluated, and potentially funded — and what legal and structural boundaries shape that process.
The tone was procedural, but the implications are significant, especially amid recent internal tensions.
Commission members reviewed a draft framework outlining how the public might submit proposals for consideration. The document described the Commission’s goals, suggested a uniform submission deadline, and emphasized that all materials would be subject to New Hampshire’s Right-to-Know law (RSA 91-A). Members stressed the importance of setting expectations clearly from the outset, noting that this is not a traditional request-for-proposals process and that the Commission may ultimately choose not to fund any submissions.
That distinction became central to the discussion.
NH Attorney General John Formella clarified that even if the Commission votes to support a proposal, the Department of Justice would serve as the contracting authority. Any contract would still need to be brought before the Governor and Council for approval, and he would not advocate for something he could not support. The layered authority structure — Commission discussion, DOJ contracting, Governor and Council approval — shapes the practical limits of the Commission’s decisions.
Questions also arose about how formal the submission process should be. Formella suggested including a short-form “concept note” option, allowing applicants to present ideas without triggering a highly structured or legally rigid review process. He cautioned against creating something that resembles a conventional RFP, which could introduce legal exposure and constrain flexibility. Other members debated whether requiring structured submissions would clarify expectations or deter participation.
Underlying much of the conversation was a more fundamental issue: timing and data.
New member, Dr. Mitchell Cohen, raised concerns about whether grants might be advanced before sufficient data demonstrates unmet need. The Commission acknowledged that assessing need must precede funding decisions and agreed that overlap with other initiatives — particularly the GO NORTH $208 million program — must be avoided. The message was clear: public expectations should not run ahead of evidence.
The meeting also touched briefly on the Commission’s name and scope. Senator Tim McGough suggested removing the word “Protection,” arguing that it might constrain the Commission’s reach. The Attorney General indicated he would need to consider the suggestion, and a related bill is under review in the House, with discussion of holding it for interim study rather than defeating it outright.
No public comments were received, no community meetings were scheduled, and no substantive discussion took place regarding the University of New Hampshire research, though UNH representatives are expected at a future session.
The Healthcare Consumer Protection Advisory Commission was created to oversee millions of dollars in funding intended to benefit consumers following a wave of hospital acquisitions and consolidation across New Hampshire. Its mandate was meant to ensure that merger-related settlements translate into tangible public benefit.
Internal Controversy
While this session may have appeared technical, it comes in the context of recent internal controversy that has drawn public attention. Prior reporting highlighted tension among members over leadership direction and clarity of mission, leading to a change in Commission membership and public discussion about the panel’s role and accountability. That backdrop — with its questions about organizational coherence and public confidence — makes the clarity around the process all the more important.hip.
Since the summer of 2024, the seven-member Commission has been chaired by Yvonne Goldsberry, president of the Endowment for Health and a longtime community health advocate. Dr. Marie Ramas, a Nashua-based primary care physician and then-president of the New Hampshire Medical Society, served as one of the two public members.
Both were recently notified that their two-year terms would not be renewed, effective immediately.
Attorney General John Formella has now assumed the role of chair, and Dr. Mitchell Cohen has been appointed to the Commission. A replacement has been named for Dr. Ramas in Jason Cole, Esq.
The abrupt transition has raised questions among observers about continuity and direction. Ramas had publicly described the leadership shift as a setback for consumers, noting her clinical and policy experience and her direct connection to practicing physicians across the state. A spokesperson for Goldsberry indicated that under her leadership the Commission had prioritized public engagement and the development of a fair and transparent process for fund distribution.
The Attorney General, while expressing gratitude for the departing members’ service, declined to elaborate on the reasons for the non-renewals. Under statute, members are appointed by the Governor.
Complicating matters further, two members of the Commission have reportedly proposed changes that would limit the Executive Council’s oversight role in expenditure approval and remove funding for academic research related to hospital mergers. That proposal, if advanced, would alter the checks-and-balances framework governing how merger-related funds are deployed.
Taken together, the leadership transition, membership changes, and proposed structural adjustments have created an atmosphere of uncertainty around the Commission’s trajectory — even as it begins to define the rules by which funding decisions will be made.
For a body created to safeguard consumer interests in the wake of hospital consolidation, clarity of governance and public trust are not peripheral concerns. They are central.
The Commission agreed that a submission deadline will be established at the next meeting and that no funding decisions will occur before that deadline. Members also left open the possibility of reopening submissions in the future. And, no public comment will be allowed at that meeting.
In public policy, outcomes often hinge on process. The February meeting did not move dollars, but it did begin to define how — and under what constraints — dollars might move in the future.
For stakeholders watching New Hampshire’s approach to health care costs and consumer oversight, the next meeting will likely provide clearer answers about deadlines, data requirements, and how the Commission intends to balance flexibility with accountability.
The next meeting of the New Hampshire Health Care Consumer Protection Advisory Commission will be at 10:30 A.M. on Monday, March 16, 2026, at the Granite Place Press Room at the offices of the New Hampshire Department of Justice. 1 Granite Place South, Concord, NH.
